Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Gabelli Healthcare & WellnessRX Trust and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers. This publication does not announce a credit rating action and is not an indication of whether or not a credit rating action is likely in the near future.

The Board of Trustees of The Gabelli Healthcare & WellnessRX Trust (NYSE:GRX) (the "Fund") authorized the redemption of all outstanding 5.76% Series A Cumulative Preferred Shares (the "Series A Preferred"). The shares will be redeemed at $25.0520 per Series A Preferred (the "Redemption Price"), which consists of $25.00 per Series A Preferred (the liquidation preference) plus accumulated and unpaid dividends and distributions to the redemption date of April 9, 2020 (the "Redemption Date").

The Board of Trustees of The Gabelli Healthcare & WellnessRx Trust (NYSE:GRX) (the "Fund") reaffirmed its quarterly distribution policy and declared a $0.14 per share cash distribution payable on June 23, 2020 to common shareholders of record on June 16, 2020.